Expression of B and T lymphocyte attenuator, retinoid‐related orphan receptor gamma‐isoform‐t and interleukin 7 in psoriasis vulgaris
Sign Up to like & getrecommendations! Published in 2019 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.12965
Abstract: Psoriasis is one of the immune‐mediated inflammatory diseases where CD4+ T lymphocytes, mainly Th1 cells, and B lymphocytes contribute in their pathogenesis through a pro‐inflammatory effect, production of antibodies, activation of T cells and cytokine… read more here.
Keywords: psoriasis; expression; psoriasis vulgaris; lymphocyte attenuator ... See more keywords
Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma
Sign Up to like & getrecommendations! Published in 2020 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2020.592811
Abstract: B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to the CD28 immunoglobulin superfamily. However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been… read more here.
Keywords: melanoma; btla; skin cutaneous; cutaneous melanoma ... See more keywords
B- and T-Lymphocyte Attenuator Expression on Regulatory T-Cells in Patients with Severe Sepsis
Sign Up to like & getrecommendations! Published in 2018 at "Chinese Medical Journal"
DOI: 10.4103/0366-6999.244104
Abstract: To the Editor: Regulatory T‐cells (Tregs), a subset of CD4+ T‐cells, have the capacity to actively suppress immune responses and play a pivotal role in sepsis‐induced immunosuppression.[1] B‐ and T‐lymphocyte attenuator (BTLA) is a co‐inhibitory… read more here.
Keywords: sepsis; btla expression; regulatory cells; expression ... See more keywords